Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19

Metronidazole (MTZ) can decrease the levels of several cytokines. This research aimed at the investigation of the anti-inflammatory impact of MTZ in COVID-19. A randomized, single-blind clinical trial for comparing the anti-inflammatory effect of MTZ in two eligible groups of adult patients with low...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazempour, Muhanna, Izadi, Hossein, Chouhdari, Arezoo, Rezaeifard, Morteza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653686/
https://www.ncbi.nlm.nih.gov/pubmed/34904006
http://dx.doi.org/10.22037/ijpr.2021.114567.14917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653686/
https://www.ncbi.nlm.nih.gov/pubmed/34904006
http://dx.doi.org/10.22037/ijpr.2021.114567.14917

Ejemplares similares